Shou Shigemoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shou Shigemoto has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Akihisa Imagawa
Department of Internal Medicine (I), Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki City, Osaka 569-8686, Japan
1 shared publication Akiko Sasagawa
Department of Internal Medicine (I), Osaka Medical and Pharmaceutical University, Takatsuki City, Japan
1 shared publicationDaisuke Watanabe
Department of Internal Medicine (I), Osaka Medical and Pharmaceutical University, Takatsuki City, Japan
1 shared publicationHiroyuki Sano
Department of Internal Medicine (I), Osaka Medical and Pharmaceutical University, Takatsuki City, Japan
1 shared publicationHisashi Imbe
Department of Internal Medicine (I), Osaka Medical and Pharmaceutical University, Takatsuki City, Japan
1 shared publicationJungo Terasaki
Department of Internal Medicine (I), Osaka Medical and Pharmaceutical University, Takatsuki City, Japan
1 shared publication
Latest Publications
- 25 May 2022
- Published by Springer Nature in Diabetology International
- Vol. 13 (4) , 679-686
Decreased cognitive function is associated with preceding severe hypoglycemia and impaired blood glucose control in the elderly individuals with type 1 diabetes
Aim/Introduction This investigation aimed to clarify the relationship between cognitive function and blood glucose control in the elderly individuals with type 1 diabetes. Materials and methods In total, 45 patients with type 1 diabetes, age 74.9 ± 6.7 years, and HbA1c levels of 7.9 ± 0.9% were studied. Severe hypoglycemia occurred in 33% of patients, and the number of severe hypoglycemia episodes was 0.6 ± 1.2 in the past 5 years before the time of the cognitive function tests. We analyzed clinical data and dementia scores on the Revised Hasegawa’s Dementia Scale (HDS-R), Mini-Mental State Examination (MMSE), and Dementia Assessment Sheet for Community-based Integrated Care System, and 21 items (DASC-21). Results There was a significant correlation between HbA1c and HDS-R, MMSE, respectively. There was a significant correlation between the number of severe hypoglycemic episodes and HDS-R, MMSE, and DASC-21, respectively. When the group with experience of severe hypoglycemia was compared to the control group, HDS-R, MMSE, and DASC-21 were meaningfully different after adjusting for age modeling analysis of covariance. Conclusions In elderly individuals with type 1 diabetes, our results suggest that high HbA1c for the past 5 years from the cognitive function test and a history of severe hypoglycemic episodes from the time of disease diagnosis are related to decreased cognitive function.
- 25 May 2022
- Published by Springer Nature in Diabetology International
- Vol. 13 (4) , 679-686
Decreased cognitive function is associated with preceding severe hypoglycemia and impaired blood glucose control in the elderly individuals with type 1 diabetes
Aim/Introduction This investigation aimed to clarify the relationship between cognitive function and blood glucose control in the elderly individuals with type 1 diabetes. Materials and methods In total, 45 patients with type 1 diabetes, age 74.9 ± 6.7 years, and HbA1c levels of 7.9 ± 0.9% were studied. Severe hypoglycemia occurred in 33% of patients, and the number of severe hypoglycemia episodes was 0.6 ± 1.2 in the past 5 years before the time of the cognitive function tests. We analyzed clinical data and dementia scores on the Revised Hasegawa’s Dementia Scale (HDS-R), Mini-Mental State Examination (MMSE), and Dementia Assessment Sheet for Community-based Integrated Care System, and 21 items (DASC-21). Results There was a significant correlation between HbA1c and HDS-R, MMSE, respectively. There was a significant correlation between the number of severe hypoglycemic episodes and HDS-R, MMSE, and DASC-21, respectively. When the group with experience of severe hypoglycemia was compared to the control group, HDS-R, MMSE, and DASC-21 were meaningfully different after adjusting for age modeling analysis of covariance. Conclusions In elderly individuals with type 1 diabetes, our results suggest that high HbA1c for the past 5 years from the cognitive function test and a history of severe hypoglycemic episodes from the time of disease diagnosis are related to decreased cognitive function.